[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global and North America Primary Progressive Multiple Sclerosis Treatment Market Status and Future Forecast 2013-2023

May 2018 | 63 pages | ID: GD17A13F13AEN
99Strategy

US$ 2,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

Key Content of Chapters (Including and can be customized)

Part 1:
Market Overview, Development, and Segment by Type, Application & Region
Part 2:
Global Market by company, Type, Application & Region
Part 3:
North America Market by company, Type, Application & Region
Part 4-6:
Key Regions of North America Market by Type, Application
Part 7:
Company information, Sales, Cost, Margin etc.
Part 8:
Conclusion

Market Segment as follows:

By Region
  • Global (North America, Europe, Asia etc.)
  • North America (United States, Canada, Mexico)
Key Companies
  • F. Hoffmann-La Roche Ltd.
  • Genzyme Corporation
  • Glialogix, Inc.
  • Kyorin Pharmaceutical Co., Ltd.
  • MedDay SA
  • Santhera Pharmaceuticals Holding AG
  • Teva Pharmaceutical Industries Ltd.
Market by Type
  • ApE
  • Biotin
  • GZ-402668
  • Ibudilast
  • Idebenone
  • Laquinimod Sodium
  • Others
Market by Application
  • Hospital
  • Clinic
  • Others
PART 1 MARKET OVERVIEW

1.1 Market Definition
1.2 Market Development
1.3 By Type
1.4 By Application
1.5 By Region

PART 2 GLOBAL MARKET STATUS AND FUTURE FORECAST

2.1 Global Market by Region
2.2 Global Market by Company
2.3 Global Market by Type
2.4 Global Market by Application
2.5 Global Market by Forecast

PART 3 NORTH AMERICA MARKET STATUS AND FUTURE FORECAST

3.1 North America Market by Region
3.2 North America Market by Company
3.3 North America Market by Type
3.4 North America Market by Application
3.5 North America Market by Forecast

PART 4 UNITED STATES MARKET STATUS AND FUTURE FORECAST

4.1 United States Market by Type
4.2 United States Market by Application
4.3 United States Market by Forecast

PART 5 CANADA MARKET STATUS AND FUTURE FORECAST

5.1 Canada Market by Type
5.2 Canada Market by Application
5.3 Canada Market by Forecast

PART 6 MEXICO MARKET STATUS AND FUTURE FORECAST

6.1 Mexico Market by Type
6.2 Mexico Market by Application
6.3 Mexico Market by Forecast

PART 7 KEY COMPANIES

7.1 F. Hoffmann-La Roche Ltd.
7.2 Genzyme Corporation
7.3 Glialogix, Inc.
7.4 Kyorin Pharmaceutical Co., Ltd.
7.5 MedDay SA
7.6 Santhera Pharmaceuticals Holding AG
7.7 Teva Pharmaceutical Industries Ltd.

PART 8 CONCLUSION

LIST OF TABLES

Table Type of Primary Progressive Multiple Sclerosis Treatment
Table Application of Primary Progressive Multiple Sclerosis Treatment
Table Global Primary Progressive Multiple Sclerosis Treatment Market by Region, 2013-2017 (Million USD)
Table Global Primary Progressive Multiple Sclerosis Treatment Market by Region, 2013-2017 (Volume)
Table Price List by Region, 2013-2017
Table Global Primary Progressive Multiple Sclerosis Treatment Market by Company, 2013-2017 (Million USD)
Table Global Primary Progressive Multiple Sclerosis Treatment Market by Company, 2013-2017 (Volume)
Table Price List by Company, 2013-2017
Table Global Primary Progressive Multiple Sclerosis Treatment Market by Type, 2013-2017 (Million USD)
Table Global Primary Progressive Multiple Sclerosis Treatment Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table Global Primary Progressive Multiple Sclerosis Treatment Market by Application, 2013-2017 (Million USD)
Table Global Primary Progressive Multiple Sclerosis Treatment Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table North America Primary Progressive Multiple Sclerosis Treatment Market by Region, 2013-2017 (Million USD)
Table North America Primary Progressive Multiple Sclerosis Treatment Market by Region, 2013-2017 (Volume)
Table Price List by Region, 2013-2017
Table North America Primary Progressive Multiple Sclerosis Treatment Market by Company, 2013-2017 (Million USD)
Table North America Primary Progressive Multiple Sclerosis Treatment Market by Company, 2013-2017 (Volume)
Table Price List by Company, 2013-2017
Table North America Primary Progressive Multiple Sclerosis Treatment Market by Type, 2013-2017 (Million USD)
Table North America Primary Progressive Multiple Sclerosis Treatment Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table North America Primary Progressive Multiple Sclerosis Treatment Market by Application, 2013-2017 (Million USD)
Table North America Primary Progressive Multiple Sclerosis Treatment Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table United States Primary Progressive Multiple Sclerosis Treatment Market by Type, 2013-2017 (Million USD)
Table United States Primary Progressive Multiple Sclerosis Treatment Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table United States Primary Progressive Multiple Sclerosis Treatment Market by Application, 2013-2017 (Million USD)
Table United States Primary Progressive Multiple Sclerosis Treatment Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table Canada Primary Progressive Multiple Sclerosis Treatment Market by Type, 2013-2017 (Million USD)
Table Canada Primary Progressive Multiple Sclerosis Treatment Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table Canada Primary Progressive Multiple Sclerosis Treatment Market by Application, 2013-2017 (Million USD)
Table Canada Primary Progressive Multiple Sclerosis Treatment Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table Mexico Primary Progressive Multiple Sclerosis Treatment Market by Type, 2013-2017 (Million USD)
Table Mexico Primary Progressive Multiple Sclerosis Treatment Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table Mexico Primary Progressive Multiple Sclerosis Treatment Market by Application, 2013-2017 (Million USD)
Table Mexico Primary Progressive Multiple Sclerosis Treatment Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table F. Hoffmann-La Roche Ltd. Information
Table Primary Progressive Multiple Sclerosis Treatment Sales, Cost, Margin of F. Hoffmann-La Roche Ltd.
Table Genzyme Corporation Information
Table Primary Progressive Multiple Sclerosis Treatment Sales, Cost, Margin of Genzyme Corporation
Table Glialogix, Inc. Information
Table Primary Progressive Multiple Sclerosis Treatment Sales, Cost, Margin of Glialogix, Inc.
Table Kyorin Pharmaceutical Co., Ltd. Information
Table Primary Progressive Multiple Sclerosis Treatment Sales, Cost, Margin of Kyorin Pharmaceutical Co., Ltd.
Table MedDay SA Information
Table Primary Progressive Multiple Sclerosis Treatment Sales, Cost, Margin of MedDay SA
Table Santhera Pharmaceuticals Holding AG Information
Table Primary Progressive Multiple Sclerosis Treatment Sales, Cost, Margin of Santhera Pharmaceuticals Holding AG
Table Teva Pharmaceutical Industries Ltd. Information
Table Primary Progressive Multiple Sclerosis Treatment Sales, Cost, Margin of Teva Pharmaceutical Industries Ltd.

LIST OF FIGURES

Figure Global Primary Progressive Multiple Sclerosis Treatment Market Share by Type in 2018
Figure Global Primary Progressive Multiple Sclerosis Treatment Market Share by Application in 2018
Figure Global Primary Progressive Multiple Sclerosis Treatment Market Share by Region in 2018
Figure North America Primary Progressive Multiple Sclerosis Treatment Market Share by Region in 2018
Figure Global Primary Progressive Multiple Sclerosis Treatment Market Share by Region in 2017 (Million USD)
Figure Global Primary Progressive Multiple Sclerosis Treatment Market Share by Region in 2017 (Volume)
Figure Global Primary Progressive Multiple Sclerosis Treatment Market Share by Company in 2017 (Million USD)
Figure Global Primary Progressive Multiple Sclerosis Treatment Market Share by Company in 2017 (Volume)
Figure Global Primary Progressive Multiple Sclerosis Treatment Market Share by Type in 2017 (Million USD)
Figure Global Primary Progressive Multiple Sclerosis Treatment Market Share by Type in 2017 (Volume)
Figure Global Primary Progressive Multiple Sclerosis Treatment Market Share by Application in 2017 (Million USD)
Figure Global Primary Progressive Multiple Sclerosis Treatment Market Share by Application in 2017 (Volume)
Figure Global Primary Progressive Multiple Sclerosis Treatment Market Forecast, 2018-2023 (Million USD)
Figure Global Primary Progressive Multiple Sclerosis Treatment Market Forecast, 2018-2023 (Volume)
Figure North America Primary Progressive Multiple Sclerosis Treatment Market Share by Region in 2017 (Million USD)
Figure North America Primary Progressive Multiple Sclerosis Treatment Market Share by Region in 2017 (Volume)
Figure North America Primary Progressive Multiple Sclerosis Treatment Market Share by Company in 2017 (Million USD)
Figure North America Primary Progressive Multiple Sclerosis Treatment Market Share by Company in 2017 (Volume)
Figure North America Primary Progressive Multiple Sclerosis Treatment Market Share by Type in 2017 (Million USD)
Figure North America Primary Progressive Multiple Sclerosis Treatment Market Share by Type in 2017 (Volume)
Figure North America Primary Progressive Multiple Sclerosis Treatment Market Share by Application in 2017 (Million USD)
Figure North America Primary Progressive Multiple Sclerosis Treatment Market Share by Application in 2017 (Volume)
Figure North America Primary Progressive Multiple Sclerosis Treatment Market Forecast, 2018-2023 (Million USD)
Figure North America Primary Progressive Multiple Sclerosis Treatment Market Forecast, 2018-2023 (Volume)
Figure United States Primary Progressive Multiple Sclerosis Treatment Market Share by Type in 2017 (Million USD)
Figure United States Primary Progressive Multiple Sclerosis Treatment Market Share by Type in 2017 (Volume)
Figure United States Primary Progressive Multiple Sclerosis Treatment Market Share by Application in 2017 (Million USD)
Figure United States Primary Progressive Multiple Sclerosis Treatment Market Share by Application in 2017 (Volume)
Figure United States Primary Progressive Multiple Sclerosis Treatment Market Forecast, 2018-2023 (Million USD)
Figure United States Primary Progressive Multiple Sclerosis Treatment Market Forecast, 2018-2023 (Volume)
Figure Canada Primary Progressive Multiple Sclerosis Treatment Market Share by Type in 2017 (Million USD)
Figure Canada Primary Progressive Multiple Sclerosis Treatment Market Share by Type in 2017 (Volume)
Figure Canada Primary Progressive Multiple Sclerosis Treatment Market Share by Application in 2017 (Million USD)
Figure Canada Primary Progressive Multiple Sclerosis Treatment Market Share by Application in 2017 (Volume)
Figure Canada Primary Progressive Multiple Sclerosis Treatment Market Forecast, 2018-2023 (Million USD)
Figure Canada Primary Progressive Multiple Sclerosis Treatment Market Forecast, 2018-2023 (Volume)
Figure Mexico Primary Progressive Multiple Sclerosis Treatment Market Share by Type in 2017 (Million USD)
Figure Mexico Primary Progressive Multiple Sclerosis Treatment Market Share by Type in 2017 (Volume)
Figure Mexico Primary Progressive Multiple Sclerosis Treatment Market Share by Application in 2017 (Million USD)
Figure Mexico Primary Progressive Multiple Sclerosis Treatment Market Share by Application in 2017 (Volume)
Figure Mexico Primary Progressive Multiple Sclerosis Treatment Market Forecast, 2018-2023 (Million USD)
Figure Mexico Primary Progressive Multiple Sclerosis Treatment Market Forecast, 2018-2023 (Volume)

More Publications

Need Help?

Ask a Question

Market Reports

All Categories